DE69636267D1 - Neues eisenchelat als hemmungsmittel von durch eisen vermittelte oxydation - Google Patents

Neues eisenchelat als hemmungsmittel von durch eisen vermittelte oxydation

Info

Publication number
DE69636267D1
DE69636267D1 DE69636267T DE69636267T DE69636267D1 DE 69636267 D1 DE69636267 D1 DE 69636267D1 DE 69636267 T DE69636267 T DE 69636267T DE 69636267 T DE69636267 T DE 69636267T DE 69636267 D1 DE69636267 D1 DE 69636267D1
Authority
DE
Germany
Prior art keywords
iron
exochelins
inhibitor
new
chelate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69636267T
Other languages
English (en)
Other versions
DE69636267T2 (de
Inventor
Lawrence Horwitz
Marcus A Horwitz
Bradford W Gibson
Joseph Reeve
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California filed Critical University of California
Application granted granted Critical
Publication of DE69636267D1 publication Critical patent/DE69636267D1/de
Publication of DE69636267T2 publication Critical patent/DE69636267T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/863—Mycobacterium
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/863—Mycobacterium
    • Y10S435/864—Mycobacterium avium
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/863—Mycobacterium
    • Y10S435/865—Mycobacterium fortuitum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/863—Mycobacterium
    • Y10S435/866—Mycobacterium smegmatis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dentistry (AREA)
  • Epidemiology (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Detergent Compositions (AREA)
  • Pyrrole Compounds (AREA)
DE69636267T 1995-02-03 1996-01-26 Neues eisenchelat als hemmungsmittel von durch eisen vermittelte oxydation Expired - Lifetime DE69636267T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/383,180 US5721209A (en) 1995-02-03 1995-02-03 Iron chelator and inhibitor of iron-mediated oxidant injury
PCT/IB1996/000171 WO1996023502A1 (en) 1995-02-03 1996-01-26 Novel iron chelator as inhibitor of iron-mediated oxidation
US383180 1999-08-25

Publications (2)

Publication Number Publication Date
DE69636267D1 true DE69636267D1 (de) 2006-08-03
DE69636267T2 DE69636267T2 (de) 2008-07-31

Family

ID=23512050

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69636267T Expired - Lifetime DE69636267T2 (de) 1995-02-03 1996-01-26 Neues eisenchelat als hemmungsmittel von durch eisen vermittelte oxydation

Country Status (13)

Country Link
US (1) US5721209A (de)
EP (1) EP0754044B1 (de)
JP (1) JP3511139B2 (de)
KR (1) KR100325970B1 (de)
CN (1) CN1209110C (de)
AT (1) ATE330610T1 (de)
AU (1) AU699916B2 (de)
CZ (1) CZ288996A3 (de)
DE (1) DE69636267T2 (de)
EA (1) EA000176B1 (de)
HU (1) HUP9603036A3 (de)
PL (1) PL182414B1 (de)
WO (1) WO1996023502A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837677A (en) * 1995-02-03 1998-11-17 Keystone Biomedical, Inc. Method for the treatment of cancer with Exochelins of Mycobacterium tuberculosis
US5786326A (en) * 1995-02-03 1998-07-28 Horwitz; Lawrence D. Method for the treatment of atherosclerosis and vascular injury by prevention of vascular smooth muscle cell proliferation
US5994346A (en) * 1995-02-03 1999-11-30 Regents Of The University Of California Use of exochelins in the preservation of organs for transplant
US6054133A (en) * 1997-07-10 2000-04-25 The Regents Of The University Of California Anti-microbial targeting for intracellular pathogens
US6063919A (en) * 1998-08-14 2000-05-16 Keystone Biomedical, Inc. Process for the synthesis of exochelins
US5952492A (en) * 1998-08-14 1999-09-14 Keystone Biomedical, Inc. Chemical synthesis of exochelins
US6933104B1 (en) * 1999-04-23 2005-08-23 Shiva Biomedical, Llc Diagnosis and treatment of human kidney diseases
US6486199B1 (en) 2001-06-21 2002-11-26 Medicines For Malaria Venture Mmv International Centre Cointrin Spiro and dispiro 1,2,4-trioxolane antimalarials
US7371778B2 (en) * 2002-06-21 2008-05-13 Medicines For Malaria Venture Mmv Spiro and dispiro 1,2,4-trioxolane antimalarials
US20080125441A1 (en) * 2002-06-21 2008-05-29 Medicines For Malaria Venture Mmv Spiro and dispiro 1,2,4-trioxolane antimalarials
US6906205B2 (en) * 2002-06-21 2005-06-14 Medicines For Malaria Venture Mmv Spiro and dispiro 1,2,4-trioxolane antimalarials
US8067620B2 (en) * 2005-05-04 2011-11-29 Medicines For Malaria Venture Mmv Dispiro 1,2,4-trioxolane antimalarials
GB0526033D0 (en) * 2005-12-21 2006-02-01 Bioeos Ltd Method

Also Published As

Publication number Publication date
HUP9603036A2 (en) 1997-05-28
HUP9603036A3 (en) 2000-07-28
KR100325970B1 (ko) 2002-07-27
ATE330610T1 (de) 2006-07-15
WO1996023502A1 (en) 1996-08-08
MX9604499A (es) 1997-11-29
HU9603036D0 (en) 1997-01-28
DE69636267T2 (de) 2008-07-31
AU699916B2 (en) 1998-12-17
EA199600078A1 (ru) 1997-09-30
AU4674496A (en) 1996-08-21
EP0754044A1 (de) 1997-01-22
JP3511139B2 (ja) 2004-03-29
PL182414B1 (pl) 2001-12-31
PL316612A1 (en) 1997-01-20
CN1145588A (zh) 1997-03-19
EP0754044B1 (de) 2006-06-21
CZ288996A3 (en) 1997-04-16
CN1209110C (zh) 2005-07-06
EA000176B1 (ru) 1998-12-24
US5721209A (en) 1998-02-24

Similar Documents

Publication Publication Date Title
DE69636267D1 (de) Neues eisenchelat als hemmungsmittel von durch eisen vermittelte oxydation
ATE402262T1 (de) Verfahren und zusammensetzungen, die eine stearoyl-coa desuturase-hscd5 verwenden
FI972628A (fi) Uudet sulfonamidit
DE60027016D1 (de) Verwendung von konjugierten linolensaüren zur topischen behandlung von zellulitis
ID29158A (id) Monoester probukol untuk pengobatan penyakit kardiovaskular dan peradangan
MA27113A1 (fr) Activateurs de glucokinase oxygenes cycloalkyle ou substitues cycloalkyle
ATE422556T1 (de) Hdac4- und hdac5-abhängige regulation der genexpression im herzen
ATE542916T1 (de) Methoden zur erzeugung von oligonukleotidlösungen
TNSN02022A1 (fr) Triazolopyridines anti-inflammatoires nouvelles, et compositions les contenant
DK0477274T3 (da) Faktor Xa baserede antikoaguleringspræparater
DE69838509D1 (de) Verwendung von rekombinanten menschlichen uteroglobin zur behandlung von fibrotischen krankheitszuständen
MXPA03001643A (es) Composiciones y metodos para el diagnostico y tratamiento de tumores.
ATE300295T1 (de) Verwendung von baclofen zur behandlung von alkoholismus
DK0791073T3 (da) Analysemetode
ATE119780T1 (de) Katabolische enzyme zur induktion des tumornekrose-faktors (tnf).
CA2185661A1 (en) Novel iron chelator and inhibitor of iron-mediated oxidation
ATE240100T1 (de) Verwendung von fc101 als hemmstoff der angiogenese zur behandlung von krebs und anderen angiogenen krankheiten
ATE216702T1 (de) Silylierungsprocess
ES2154648T3 (es) Deteccion y amplificacion de acidos nucleicos blanco con actividad exonucleolitica.
CA2246236A1 (en) Treatment and prevention of adverse effects of reactive oxygen species
DE69105121T2 (de) Gewebeplasminogenaktivator mit fibrin-spezifischen eigenschaften.
MXPA03001644A (es) Composiciones y metodos para el diagnostico y tratamiento de tumor.
BR0017074A (pt) Combinações de inibidor de ace-antagonista de vasopressina
ATE69609T1 (de) Cardiotonische imidazolylphenylpyrrol-2-one.
DE69105213T2 (de) Substitutionsvariante des gewebeplasminogenaktivators.

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication related to discontinuation of the patent is to be deleted
8364 No opposition during term of opposition